These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8717507)

  • 1. Immunotoxins: an update.
    Thrush GR; Lark LR; Clinchy BC; Vitetta ES
    Annu Rev Immunol; 1996; 14():49-71. PubMed ID: 8717507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant immunotoxins for treating cancer.
    FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I
    Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of immunotoxins in leukemia and lymphoma.
    Winkler U; Barth S; Schnell R; Diehl V; Engert A
    Ann Oncol; 1997; 8 Suppl 1():139-46. PubMed ID: 9187448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxins: current use and future prospects in bone marrow transplantation and cancer treatment.
    Neville DM
    Crit Rev Ther Drug Carrier Syst; 1986; 2(4):329-52. PubMed ID: 3549005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
    Byers VS; Baldwin RW
    Semin Cell Biol; 1991 Feb; 2(1):59-70. PubMed ID: 1954344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxins and cytokine toxin fusion proteins.
    Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
    Semin Immunol; 1990 Nov; 2(6):467-79. PubMed ID: 2104283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted antibodies in the treatment of lymphomas.
    Falini B; Terenzi A; Liso A; Flenghi L; Solinas A; Pasqualucci L
    Cancer Surv; 1997; 30():295-309. PubMed ID: 9547998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective tumor targeting: strategies for the delivery of Armed Antibodies.
    MacDonald GC; Glover N
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):177-83. PubMed ID: 15782542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of immunotoxins.
    Cobb PW; LeMaistre CF
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxins: magic bullets or misguided missiles?
    Vitetta ES; Thorpe PE; Uhr JW
    Immunol Today; 1993 Jun; 14(6):252-9. PubMed ID: 8397766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxins for the therapy of graft versus host disease.
    Salzman D; LeMaistre F
    Cancer Treat Res; 1993; 68():133-44. PubMed ID: 8105848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
    Lorberboum-Galski H
    Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting T cells for GVHD therapy.
    Vallera DA
    Semin Cancer Biol; 1996 Apr; 7(2):57-64. PubMed ID: 8740560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotoxins and cancer therapy.
    Li Z; Yu T; Zhao P; Ma J
    Cell Mol Immunol; 2005 Apr; 2(2):106-12. PubMed ID: 16191416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of anticancer immunotoxins.
    Choudhary S; Mathew M; Verma RS
    Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel genetic immunotoxins and intracellular antibodies for cancer therapy.
    Chen SY; Marasco WA
    Semin Oncol; 1996 Feb; 23(1):148-53. PubMed ID: 8607024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin conjugate therapy of cancer.
    Wong L; Suh DY; Frankel AE
    Semin Oncol; 2005 Dec; 32(6):591-5. PubMed ID: 16338425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.